Biodexa Pharmaceuticals (BDRX) Preferred Dividend Payments (2014 - 2024)

Biodexa Pharmaceuticals has reported Preferred Dividend Payments for 6 years, with the latest figure at -$1.0 million in Q4 2024.

• Quarterly Preferred Dividend Payments fell 16632.09% year-over-year to -$1.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$1.1 million (down 834.01% YoY) and the FY2024 annual result came in at -$1.0 million, down 16596.15% from the prior year.
• Preferred Dividend Payments fell to -$1.0 million in Q4 2024 per BDRX's latest filing, from -$6205.8 in the prior quarter.
• Over five years, Preferred Dividend Payments peaked at -$2696.0 in Q4 2021 and troughed at -$1.0 million in Q4 2024.
• A 5-year average of -$230196.1 and a median of -$6205.8 in 2023 frame the typical range for Preferred Dividend Payments.
• The sharpest annual moves came in 2021 and 2024: Preferred Dividend Payments jumped 97.28% in 2021, then tumbled 16632.09% in 2024.
• Over 5 years, Preferred Dividend Payments stood at -$99033.8 in 2020, then surged by 97.28% to -$2696.0 in 2021, then plunged by 74.02% to -$4691.7 in 2022, then slumped by 32.27% to -$6205.8 in 2023, then sank by 16632.09% to -$1.0 million in 2024.
• According to Business Quant data, Preferred Dividend Payments over the past three periods registered -$1.0 million, -$6205.8, and -$4691.7 for Q4 2024, Q4 2023, and Q4 2022 respectively.